Importantly, there was no association between DRG2 expression level and ATRX loss in multiple cancer types which are rarely ALT-positive, that is, where ATRX loss is likely a random passenger event rather than central to oncogenesis (Supplementary Fig. S4B). The gene discussed is GPT; the disease is cancer.